Single-Cell Transcriptomics of Distinct Cell States in NRAS-Mutated Melanoma Transitioning to Drug Resistance: Elevated P2RX7 Levels Indicate Response to Targeted Therapy Article Swipe
Tijana Randic
,
Stefano Magni
,
Demetra Philippidou
,
Kamil Grzyb
,
Jasmin Renate Preis
,
Christiane Margue
,
Petr V. Nazarov
,
Michel Mittelbronn
,
Katrin Frauenknecht
,
Alexander Skupin
,
Stephanie Kreis
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.2139/ssrn.4295386
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.2139/ssrn.4295386
Related Topics
Concepts
Neuroblastoma RAS viral oncogene homolog
Melanoma
Drug
Drug resistance
Cancer research
Targeted therapy
Cell
Medicine
Vemurafenib
Transcriptome
Oncology
Pharmacology
Biology
Internal medicine
Cancer
Genetics
Gene
Metastatic melanoma
Gene expression
KRAS
Colorectal cancer
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.2139/ssrn.4295386
- OA Status
- green
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4313158610
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4313158610Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2139/ssrn.4295386Digital Object Identifier
- Title
-
Single-Cell Transcriptomics of Distinct Cell States in NRAS-Mutated Melanoma Transitioning to Drug Resistance: Elevated P2RX7 Levels Indicate Response to Targeted TherapyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-01-01Full publication date if available
- Authors
-
Tijana Randic, Stefano Magni, Demetra Philippidou, Kamil Grzyb, Jasmin Renate Preis, Christiane Margue, Petr V. Nazarov, Michel Mittelbronn, Katrin Frauenknecht, Alexander Skupin, Stephanie KreisList of authors in order
- Landing page
-
https://doi.org/10.2139/ssrn.4295386Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.2139/ssrn.4295386Direct OA link when available
- Concepts
-
Neuroblastoma RAS viral oncogene homolog, Melanoma, Drug, Drug resistance, Cancer research, Targeted therapy, Cell, Medicine, Vemurafenib, Transcriptome, Oncology, Pharmacology, Biology, Internal medicine, Cancer, Genetics, Gene, Metastatic melanoma, Gene expression, KRAS, Colorectal cancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4313158610 |
|---|---|
| doi | https://doi.org/10.2139/ssrn.4295386 |
| ids.doi | https://doi.org/10.2139/ssrn.4295386 |
| ids.openalex | https://openalex.org/W4313158610 |
| fwci | 0.1489647 |
| type | article |
| title | Single-Cell Transcriptomics of Distinct Cell States in NRAS-Mutated Melanoma Transitioning to Drug Resistance: Elevated P2RX7 Levels Indicate Response to Targeted Therapy |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11491 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9652000069618225 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | CAR-T cell therapy research |
| topics[1].id | https://openalex.org/T10207 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9186999797821045 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Advanced biosensing and bioanalysis techniques |
| topics[2].id | https://openalex.org/T11289 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9139000177383423 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Single-cell and spatial transcriptomics |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C21790070 |
| concepts[0].level | 5 |
| concepts[0].score | 0.7000323534011841 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q18030215 |
| concepts[0].display_name | Neuroblastoma RAS viral oncogene homolog |
| concepts[1].id | https://openalex.org/C2777658100 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6551569700241089 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q180614 |
| concepts[1].display_name | Melanoma |
| concepts[2].id | https://openalex.org/C2780035454 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5646865367889404 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[2].display_name | Drug |
| concepts[3].id | https://openalex.org/C114851261 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5631363391876221 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12147416 |
| concepts[3].display_name | Drug resistance |
| concepts[4].id | https://openalex.org/C502942594 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5220515727996826 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[4].display_name | Cancer research |
| concepts[5].id | https://openalex.org/C2781230642 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5214816331863403 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q492646 |
| concepts[5].display_name | Targeted therapy |
| concepts[6].id | https://openalex.org/C1491633281 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4909985363483429 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7868 |
| concepts[6].display_name | Cell |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.48974084854125977 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C2776131300 |
| concepts[8].level | 4 |
| concepts[8].score | 0.4732535481452942 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q423111 |
| concepts[8].display_name | Vemurafenib |
| concepts[9].id | https://openalex.org/C162317418 |
| concepts[9].level | 4 |
| concepts[9].score | 0.4274095594882965 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q252857 |
| concepts[9].display_name | Transcriptome |
| concepts[10].id | https://openalex.org/C143998085 |
| concepts[10].level | 1 |
| concepts[10].score | 0.324313759803772 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[10].display_name | Oncology |
| concepts[11].id | https://openalex.org/C98274493 |
| concepts[11].level | 1 |
| concepts[11].score | 0.31042608618736267 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[11].display_name | Pharmacology |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.26515793800354004 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C126322002 |
| concepts[13].level | 1 |
| concepts[13].score | 0.21885892748832703 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[13].display_name | Internal medicine |
| concepts[14].id | https://openalex.org/C121608353 |
| concepts[14].level | 2 |
| concepts[14].score | 0.20186543464660645 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[14].display_name | Cancer |
| concepts[15].id | https://openalex.org/C54355233 |
| concepts[15].level | 1 |
| concepts[15].score | 0.19326865673065186 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[15].display_name | Genetics |
| concepts[16].id | https://openalex.org/C104317684 |
| concepts[16].level | 2 |
| concepts[16].score | 0.17772918939590454 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[16].display_name | Gene |
| concepts[17].id | https://openalex.org/C2994587330 |
| concepts[17].level | 3 |
| concepts[17].score | 0.120461106300354 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q180614 |
| concepts[17].display_name | Metastatic melanoma |
| concepts[18].id | https://openalex.org/C150194340 |
| concepts[18].level | 3 |
| concepts[18].score | 0.10099667310714722 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[18].display_name | Gene expression |
| concepts[19].id | https://openalex.org/C2781187634 |
| concepts[19].level | 4 |
| concepts[19].score | 0.07543283700942993 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q20969980 |
| concepts[19].display_name | KRAS |
| concepts[20].id | https://openalex.org/C526805850 |
| concepts[20].level | 3 |
| concepts[20].score | 0.0 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[20].display_name | Colorectal cancer |
| keywords[0].id | https://openalex.org/keywords/neuroblastoma-ras-viral-oncogene-homolog |
| keywords[0].score | 0.7000323534011841 |
| keywords[0].display_name | Neuroblastoma RAS viral oncogene homolog |
| keywords[1].id | https://openalex.org/keywords/melanoma |
| keywords[1].score | 0.6551569700241089 |
| keywords[1].display_name | Melanoma |
| keywords[2].id | https://openalex.org/keywords/drug |
| keywords[2].score | 0.5646865367889404 |
| keywords[2].display_name | Drug |
| keywords[3].id | https://openalex.org/keywords/drug-resistance |
| keywords[3].score | 0.5631363391876221 |
| keywords[3].display_name | Drug resistance |
| keywords[4].id | https://openalex.org/keywords/cancer-research |
| keywords[4].score | 0.5220515727996826 |
| keywords[4].display_name | Cancer research |
| keywords[5].id | https://openalex.org/keywords/targeted-therapy |
| keywords[5].score | 0.5214816331863403 |
| keywords[5].display_name | Targeted therapy |
| keywords[6].id | https://openalex.org/keywords/cell |
| keywords[6].score | 0.4909985363483429 |
| keywords[6].display_name | Cell |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.48974084854125977 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/vemurafenib |
| keywords[8].score | 0.4732535481452942 |
| keywords[8].display_name | Vemurafenib |
| keywords[9].id | https://openalex.org/keywords/transcriptome |
| keywords[9].score | 0.4274095594882965 |
| keywords[9].display_name | Transcriptome |
| keywords[10].id | https://openalex.org/keywords/oncology |
| keywords[10].score | 0.324313759803772 |
| keywords[10].display_name | Oncology |
| keywords[11].id | https://openalex.org/keywords/pharmacology |
| keywords[11].score | 0.31042608618736267 |
| keywords[11].display_name | Pharmacology |
| keywords[12].id | https://openalex.org/keywords/biology |
| keywords[12].score | 0.26515793800354004 |
| keywords[12].display_name | Biology |
| keywords[13].id | https://openalex.org/keywords/internal-medicine |
| keywords[13].score | 0.21885892748832703 |
| keywords[13].display_name | Internal medicine |
| keywords[14].id | https://openalex.org/keywords/cancer |
| keywords[14].score | 0.20186543464660645 |
| keywords[14].display_name | Cancer |
| keywords[15].id | https://openalex.org/keywords/genetics |
| keywords[15].score | 0.19326865673065186 |
| keywords[15].display_name | Genetics |
| keywords[16].id | https://openalex.org/keywords/gene |
| keywords[16].score | 0.17772918939590454 |
| keywords[16].display_name | Gene |
| keywords[17].id | https://openalex.org/keywords/metastatic-melanoma |
| keywords[17].score | 0.120461106300354 |
| keywords[17].display_name | Metastatic melanoma |
| keywords[18].id | https://openalex.org/keywords/gene-expression |
| keywords[18].score | 0.10099667310714722 |
| keywords[18].display_name | Gene expression |
| keywords[19].id | https://openalex.org/keywords/kras |
| keywords[19].score | 0.07543283700942993 |
| keywords[19].display_name | KRAS |
| language | en |
| locations[0].id | doi:10.2139/ssrn.4295386 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210172589 |
| locations[0].source.issn | 1556-5068 |
| locations[0].source.type | repository |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1556-5068 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | SSRN Electronic Journal |
| locations[0].source.host_organization | https://openalex.org/I1318003438 |
| locations[0].source.host_organization_name | RELX Group (Netherlands) |
| locations[0].source.host_organization_lineage | https://openalex.org/I1318003438 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | SSRN Electronic Journal |
| locations[0].landing_page_url | https://doi.org/10.2139/ssrn.4295386 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5029372363 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2856-1788 |
| authorships[0].author.display_name | Tijana Randic |
| authorships[0].countries | LU |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[0].affiliations[0].raw_affiliation_string | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[0].institutions[0].id | https://openalex.org/I186903577 |
| authorships[0].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[0].institutions[0].country_code | LU |
| authorships[0].institutions[0].display_name | University of Luxembourg |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Tijana Randic |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[1].author.id | https://openalex.org/A5089094325 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8649-3616 |
| authorships[1].author.display_name | Stefano Magni |
| authorships[1].countries | LU |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[1].affiliations[0].raw_affiliation_string | Universite du Luxembourg - Luxembourg Centre for Systems Biomedicine |
| authorships[1].institutions[0].id | https://openalex.org/I186903577 |
| authorships[1].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[1].institutions[0].country_code | LU |
| authorships[1].institutions[0].display_name | University of Luxembourg |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Stefano Magni |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Universite du Luxembourg - Luxembourg Centre for Systems Biomedicine |
| authorships[2].author.id | https://openalex.org/A5026394403 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Demetra Philippidou |
| authorships[2].countries | LU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[2].affiliations[0].raw_affiliation_string | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[2].institutions[0].id | https://openalex.org/I186903577 |
| authorships[2].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[2].institutions[0].country_code | LU |
| authorships[2].institutions[0].display_name | University of Luxembourg |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Demetra Philippidou |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[3].author.id | https://openalex.org/A5072384574 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2416-9500 |
| authorships[3].author.display_name | Kamil Grzyb |
| authorships[3].countries | LU |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[3].affiliations[0].raw_affiliation_string | Universite du Luxembourg - Center for Systems Biomedicine |
| authorships[3].institutions[0].id | https://openalex.org/I186903577 |
| authorships[3].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[3].institutions[0].country_code | LU |
| authorships[3].institutions[0].display_name | University of Luxembourg |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kamil Grzyb |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Universite du Luxembourg - Center for Systems Biomedicine |
| authorships[4].author.id | https://openalex.org/A5015230570 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Jasmin Renate Preis |
| authorships[4].countries | LU |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[4].affiliations[0].raw_affiliation_string | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[4].institutions[0].id | https://openalex.org/I186903577 |
| authorships[4].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[4].institutions[0].country_code | LU |
| authorships[4].institutions[0].display_name | University of Luxembourg |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jasmin Renate Preis |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[5].author.id | https://openalex.org/A5020175101 |
| authorships[5].author.orcid | https://orcid.org/0009-0003-6357-8811 |
| authorships[5].author.display_name | Christiane Margue |
| authorships[5].countries | LU |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[5].affiliations[0].raw_affiliation_string | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[5].institutions[0].id | https://openalex.org/I186903577 |
| authorships[5].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[5].institutions[0].country_code | LU |
| authorships[5].institutions[0].display_name | University of Luxembourg |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Christiane Margue |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[6].author.id | https://openalex.org/A5013957833 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-3443-0298 |
| authorships[6].author.display_name | Petr V. Nazarov |
| authorships[6].countries | LU |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[6].affiliations[0].raw_affiliation_string | Luxembourg Institute of Health (LIH) - Department of Cancer Research |
| authorships[6].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[6].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[6].institutions[0].type | nonprofit |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[6].institutions[0].country_code | LU |
| authorships[6].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Petr Nazarov |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Luxembourg Institute of Health (LIH) - Department of Cancer Research |
| authorships[7].author.id | https://openalex.org/A5017640916 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2998-052X |
| authorships[7].author.display_name | Michel Mittelbronn |
| authorships[7].countries | LU |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[7].affiliations[0].raw_affiliation_string | Universite du Luxembourg - Luxembourg Centre for Systems Biomedicine |
| authorships[7].institutions[0].id | https://openalex.org/I186903577 |
| authorships[7].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[7].institutions[0].country_code | LU |
| authorships[7].institutions[0].display_name | University of Luxembourg |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Michel Mittelbronn |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Universite du Luxembourg - Luxembourg Centre for Systems Biomedicine |
| authorships[8].author.id | https://openalex.org/A5008723759 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Katrin Frauenknecht |
| authorships[8].countries | LU |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210101141 |
| authorships[8].affiliations[0].raw_affiliation_string | Luxembourg Institute of Health (LIH) - Luxembourg Center of Neuropathology |
| authorships[8].institutions[0].id | https://openalex.org/I4210101141 |
| authorships[8].institutions[0].ror | https://ror.org/012m8gv78 |
| authorships[8].institutions[0].type | nonprofit |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210101141 |
| authorships[8].institutions[0].country_code | LU |
| authorships[8].institutions[0].display_name | Luxembourg Institute of Health |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Katrin Frauenknecht |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Luxembourg Institute of Health (LIH) - Luxembourg Center of Neuropathology |
| authorships[9].author.id | https://openalex.org/A5055431881 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-8955-8304 |
| authorships[9].author.display_name | Alexander Skupin |
| authorships[9].countries | LU |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[9].affiliations[0].raw_affiliation_string | University of Luxembourg - Luxembourg Centre for Systems Biomedicine (LCSB) |
| authorships[9].institutions[0].id | https://openalex.org/I186903577 |
| authorships[9].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[9].institutions[0].country_code | LU |
| authorships[9].institutions[0].display_name | University of Luxembourg |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Alexander Skupin |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | University of Luxembourg - Luxembourg Centre for Systems Biomedicine (LCSB) |
| authorships[10].author.id | https://openalex.org/A5072501227 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-1865-3889 |
| authorships[10].author.display_name | Stephanie Kreis |
| authorships[10].countries | LU |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I186903577 |
| authorships[10].affiliations[0].raw_affiliation_string | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| authorships[10].institutions[0].id | https://openalex.org/I186903577 |
| authorships[10].institutions[0].ror | https://ror.org/036x5ad56 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I186903577 |
| authorships[10].institutions[0].country_code | LU |
| authorships[10].institutions[0].display_name | University of Luxembourg |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Stephanie Kreis |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | University of Luxembourg - Department of Life Sciences and Medicine (DLSM) |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.2139/ssrn.4295386 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Single-Cell Transcriptomics of Distinct Cell States in NRAS-Mutated Melanoma Transitioning to Drug Resistance: Elevated P2RX7 Levels Indicate Response to Targeted Therapy |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11491 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9652000069618225 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | CAR-T cell therapy research |
| related_works | https://openalex.org/W2796527216, https://openalex.org/W2404580886, https://openalex.org/W2528389484, https://openalex.org/W2922270413, https://openalex.org/W2903579097, https://openalex.org/W2053578467, https://openalex.org/W2604898693, https://openalex.org/W2533139534, https://openalex.org/W2994653908, https://openalex.org/W35498444 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.2139/ssrn.4295386 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210172589 |
| best_oa_location.source.issn | 1556-5068 |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1556-5068 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | SSRN Electronic Journal |
| best_oa_location.source.host_organization | https://openalex.org/I1318003438 |
| best_oa_location.source.host_organization_name | RELX Group (Netherlands) |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1318003438 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | SSRN Electronic Journal |
| best_oa_location.landing_page_url | https://doi.org/10.2139/ssrn.4295386 |
| primary_location.id | doi:10.2139/ssrn.4295386 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210172589 |
| primary_location.source.issn | 1556-5068 |
| primary_location.source.type | repository |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1556-5068 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | SSRN Electronic Journal |
| primary_location.source.host_organization | https://openalex.org/I1318003438 |
| primary_location.source.host_organization_name | RELX Group (Netherlands) |
| primary_location.source.host_organization_lineage | https://openalex.org/I1318003438 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | SSRN Electronic Journal |
| primary_location.landing_page_url | https://doi.org/10.2139/ssrn.4295386 |
| publication_date | 2022-01-01 |
| publication_year | 2022 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.75 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.51480008 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |